Sepracor Inc. (Nasdaq: SEPR) said the FDA received an abbreviated new drug application from Breath Limited ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE